|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives and the risk of cardiovascular disease. |
| Medical Letter on Drugs and Therapeutics. 1983 Jul 22;25(640):69-70. |
| Recent epidemiological evidence suggests that the risk of serious cardiovascular complications from oral |
| contraceptives (OCs) may be related not only to the amount of estrogen in each product but also to the potency of the |
| progestin. Combination OCs with 30-35 mcg of estrogen have the same potency as those with 50 mcg with less risk |
| of cardiovascular side effects, especially in women over age 35 who are smokers. More potent progestins have been |
| associated with higher plasma concentration of low-density lipoprotein (LDL) cholesterol and lower concentrations of |
| high-density lipoprotein (HDL) cholesterol; high LDL and low HDL cholesterol levels have been associated with an |
| increased risk of coronary heart disease. 1 large survey of OC use in the UK found an association between progestin |
| dose and the incidence of death due to stroke and ischemic heart disease. Many of these findings used progestin |
| doses higher than those found in contraceptive tablets currently available in the US. Some disadvantages of low |
| dose OCs are higher rates of spotting, breakthrough bleeding, and amenorrhea. OCs containing over 20 and less |
| than 50 mcg of estrogen with a low potency progestin offer the best combination of effectiveness and safety from |
| combinations. (PubHealth.info Document ID: CONT5T 2072-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives and the risk of cardiovascular |
| disease.", is(are) . The source of this article is "Medical Letter on Drugs and Therapeutics. 1983 Jul 22;25(640):69- |
| 70.". This article was published in 1983 in English language(s). (PubHealth.info® Document ID: CONT5T 2072-06. |
| All rights reserved with PubHealth.info) PIN: 22072 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |